Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

Discover how Bruker is advancing live single-cell functional analysis, helping to accelerate breakthroughs in immunology and ...

OncoHost has won a €2.5m ($2.8m) grant to develop a novel biomarker capable of predicting cancer patient responses to immunotherapy.

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, together with its esteemed partners Heidelberg University Hospital, European Institute of ...

The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a ...